PERSKY MARLA sold 9.8% of their position (15.50K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $119.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/12/2025ACC: 0001867096-25-000147
Director
Since Oct 2021
-15.50K
Net shares
Net seller
$119.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.50K
Price / share
$7.72
Trade value
$119.61K
% of position
9.8%
9/11/2025
157.50K→142K
Total
Net shares
−15.50K
Net value
-$119.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2025 | S · Sale | −15.50K | $7.72 | $119.61K | 9.8% | 157.50K | 142K |
| Total | −15.50K | -$119.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.37K
Total
6.37K indirect6.37K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.37K | Indirect |
| Total | 6.37K | 6.37K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported